“Advances in Medical and Surgical Management of Thyroid Cancer” provides evidence-based updates on the contemporary management of thyroid cancer, from diagnosis to treatment. A
diverse faculty of Endocrinologists, Surgeons, Pathologists and more will cover nodule evaluation, molecular marker utility, active surveillance of low risk cancer, extent of initial surgery, selective
use of I-131 use, risk stratification, XRT, management of advanced disease and more. Individual cases will be presented in an interactive format with panel experts.